This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Theravance Biopharma R&d IP, LLC. Active years: 2018-2023.
Company Filing History:
Years Active: 2018-2023
Title: Michael Simeone: Innovator in Pharmaceutical Chemistry
Introduction
Michael Simeone is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on innovative compounds that have potential therapeutic applications.
Latest Patents
One of Michael Simeone's latest patents is for a crystalline form of (2S,4R)-5-(5'-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid. This invention relates to a crystalline form of the structure or a pharmaceutically acceptable salt thereof, which exhibits neprilysin inhibition activity. Additionally, the patent covers pharmaceutical compositions that include this crystalline form, methods of using it, and processes for preparing both soluble and crystalline forms.
Career Highlights
Michael Simeone is currently associated with Theravance Biopharma R&D IP, LLC, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions in the pharmaceutical industry.
Collaborations
Michael collaborates with talented individuals such as Adam D Hughes and Melissa Fleury, contributing to a dynamic research environment that fosters innovation.
Conclusion
Michael Simeone's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in therapeutic applications.